Home › Metastatic Cancer › New Jersey
Metastatic Cancer clinical trials in New Jersey
42 studies for Metastatic Cancer are looking for participants at sites in New Jersey.
Cities in New Jersey
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New Jersey, East Brunswick
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06270706Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Hunterdon Medical Center, Flemington
- Monmouth Medical Center Southern Campus, Lakewood
- Cooperman Barnabas Medical Center, Livingston
- and 6 more
RecruitingPhase 2
All ages · All sexes · Updated Nov 12, 2026 · NCT05564377Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
- Atlantic Health System Hospital, Morristown
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT05394103Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Regional Cancer Care, Belleville
- Astera Cancer Care, East Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07562152A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- John Theurer Cancer Center at Hackensack UMC, Hackensack
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Nov 5, 2026 · NCT06586957A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Jefferson Health - Cherry Hill, Cherry Hill
- Sidney Kimmel Cancer Center - Washington Township, Sewell
- Atlantic Health System Overlook Medical Center, Summit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07174336Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
- Hackensack University Medical Center, Hackensack
RecruitingPhase 2
Ages 8 to 30 · All sexes · Updated Nov 4, 2026 · NCT05726383VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Englewood Hospital and Medical Center (site 202), Englewood
- Summit Medical Group (site 205), Florham Park
- Atlantic Health System, Morristown Medical Center (site 124), Morristown
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Nov 4, 2026 · NCT03556228A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The Valley Hospital, Inc., Paramus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07638371EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Morristown Medical Center, Morristown
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07262619Pluvicto Real-world Investigation in Survival in Metastatic CRPC
- Novartis, East Hanover
RecruitingObservational study
Ages 18 and older · Men · Updated Oct 30, 2026 · NCT07697989A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Hackensack University Medical Center, Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07094204E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- Rutgers Cancer Institute, New Brunswick
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05686226First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
- Astera Cancer Care, East Brunswick
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT05875168A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Atlantic Health System / Morristown Medical Center, Morristown
- Jack & Sheryl Morris Cancer Center, New Brunswick
- Rutgers Cancer Institute, New Brunswick
- and 3 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06989437A Study of ASP3082 in Adults With Advanced Solid Tumors
- Hackensack University Medical Center, Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT05382559A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0105), Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT07030712Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- MSK Basking Ridge, Basking Ridge
- MSK Monmouth, Middletown
- MSK Bergen, Montvale
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT07227415A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Astera Cancer Care, East Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT07218380A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 12, Morristown
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07085091A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Astera, LLC, East Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- John Theurer Cancer Center, Hackensack
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07543055A Study of ZEN003694 in People With Squamous Cell Lung Cancer
- Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT05607108SLV-154 Treatment of Advanced Cancers
- Astera Cancer Care, East Brunswick
RecruitingPhase 1
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT06771219A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Hackensack University Medical Center, Hackensack
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07629960A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Atlantic Health, Morristown
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04913285A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05837767Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Hunterdon Medical Center, Flemington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT05859074Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Camden
- Research Site, Paramus
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- John Theurer Cancer Center, Hackensack
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Jul 14, 2026 · NCT05533697Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer
- The Valley Hospital-Luckow Pavilion, Paramus
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Jun 5, 2026 · NCT05232409Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
- RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton
- RWJBarnabas Health - Monmouth Medical Center Southern Campus, Lakewood
- RWJBarnabas Health - Saint Barnabas Medical Center, Livingston
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 2, 2026 · NCT05419518Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
- Jefferson Health New Jersey, Sewell
Recruiting
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT03184038A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All protocol activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 11, 2026 · NCT05010031A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT05562791Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
- Hackensack University Medical Center, Hackensack
- Atlantic Health System, Morristown
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06947928A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 6 to 49 · All sexes · Updated Mar 17, 2026 · NCT07477457A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
- Atlantic Health, Summit
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 27, 2026 · NCT07049055From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.